Iddo Magen

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

IsomiR Utility in Amyotrophic Lateral Sclerosis Prognostication.

IsomiR Utility in Amyotrophic Lateral Sclerosis Prognostication.

Journal: medRxiv : the preprint server for health sciences

Published: June 04, 2025

IsomiR utility in amyotrophic lateral sclerosis prognostication.

IsomiR utility in amyotrophic lateral sclerosis prognostication.

Journal: Med (New York, N.Y.)

Published: May 28, 2025

Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation study.

Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation study.

Journal: EBioMedicine

Published: May 20, 2025

Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS.

Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 06, 2025

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis.

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis.

Journal: medRxiv : the preprint server for health sciences

Published: August 26, 2024

predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseases.

predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseases.

Journal: bioRxiv : the preprint server for biology

Published: August 02, 2024

Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis.

Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis.

Journal: EBioMedicine

Published: February 08, 2024

Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models.

Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models.

Journal: Nature neuroscience

Published: December 14, 2023

microRNA-based predictor for diagnosis of frontotemporal dementia.

microRNA-based predictor for diagnosis of frontotemporal dementia.

Journal: Neuropathology and applied neurobiology

Published: January 06, 2023

Neutrophil to-lymphocyte and platelet-to-lymphocyte ratios as biomarkers for suicidal behavior in children and adolescents with depression or anxiety treated with selective serotonin reuptake inhibitors.

Neutrophil to-lymphocyte and platelet-to-lymphocyte ratios as biomarkers for suicidal behavior in children and adolescents with depression or anxiety treated with selective serotonin reuptake inhibitors.

Journal: Brain, behavior, and immunity

Published: March 08, 2022

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients.

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients.

Journal: European journal of neurology

Published: February 11, 2022

Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice.

Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice.

Journal: Physiology & behavior

Published: October 22, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026